Sundrug Co., Ltd. · TSE:9989

Sundrug — H1 FY3/27 Earnings Presentation

18 slides from Sundrug's earnings presentation, Nov 13, 2026

  1. Slide 1: 1H FY3/27 Results Briefing Presentation

    1H FY3/27 Results Briefing Presentation November 13, 2026 Copyright (C) SUNDRUG CO, LTD. ALL RIGHTS RESERVED.

  2. Slide 2: Contents

    Contents ◼ 1H FY3/27 Results Summary ◼ FY3/27 Full-Year Guidance ◼ Management Issues Copyright (C) SUNDRUG CO, LTD. ALL RIGHTS RESERVED. 2

  3. Slide 3: 1H FY3/27 Results Summary

    1H FY3/27 Results Summary Copyright (C) SUNDRUG CO, LTD. ALL RIGHTS RESERVED.

  4. Slide 4: 1H FY3/27 Financial Highlights [Consolidated]

    1H FY3/27 Financial Highlights [Consolidated] 1H FY3/27 results Net sales Operating income EBITDA ¥433.4 billion ¥24.0 billion ¥33.5 billion YoY +3.6% YoY +4.2% YoY +4.7% Vs. guidance -0.2% Vs. guidance +2.3% Vs. guidance +1.1% Net sales and income both reached record highs for the first half Operat

  5. Slide 5: Consolidated Income Statement

    Consolidated Income Statement 1H FY3/27 (millions of yen) Guidance Results Breakdown Breakdown Vs. guidance YoY change Net sales 434,500 100.0% 433,475 100.0% -0.2% 3.6% Gross profit 112,200 25.8% 112,307 25.9% 0.1% 5.0% SG&A expenses 88,700 20.4% 88,276 20.4% -0.5% 5.3% Labor cost 38,690 8.9% 38,36

  6. Slide 6: Consolidated Income Statement By Business

    Consolidated Income Statement By Business Drugstore 1H FY3/27 (millions of yen) business Guidance Breakdown Results Breakdown Vs. guidance YoY change Net sales 274,100 100.0% 273,741 100.0% -0.1% 2.5% Gross profit 77,500 28.3% 77,405 28.3% -0.1% 4.0% SG&A expenses 63,900 23.3% 63,597 23.2% -0.5% 4.0

  7. Slide 7: Same-Store Sales

    Same-Store Sales ◼ Same-store Group performance  1H: +0.6 Same-store sales growth by business (YoY) Drugstore business Discount store business (%) FY3/26 FY3/27 (%) FY3/26 FY3/27 5.5 4.7 4.5 5.5 4.4 4.5 3.6 3.7 3.1 3.2 3.3 3.1 2.6 2.6 1.8 1.2 3.6 0.3 0.6 0.0 0.8 0.5 1.6 0.1 1.9 2.5 2.3 -0.2 0 -0.9

  8. Slide 8: Net Sales By Category

    Net Sales By Category (millions of yen) 1H FY3/26 1H FY3/27 Drugstore business Results Breakdown Results Breakdown YoY change Health care 70,487 26.4% 70,675 25.8% 0.3% Housekeeping 57,182 21.4% 59,986 21.9% 4.9% Beauty care 77,517 29.0% 80,226 29.3% 3.5% Food 49,557 18.6% 50,342 18.4% 1.6% Other 12

  9. Slide 9: Consolidated Balance Sheet

    Consolidated Balance Sheet FY3/26 FY3/27 (millions of yen) (millions of yen) (millions of yen) Total assets: 475,505 Total assets: 477,954 Current assets -40 (Equity ratio 60.1%) (Equity ratio 61.5%) Cash and cash equivalents -4,101 Accounts receivable -517 Liabilities Liabilities Inventories +5,005

  10. Slide 10: Consolidated Cash Flows

    Consolidated Cash Flows 1H FY3/26 1H FY3/27 (millions of yen) (millions of yen) Operating Investing Operating Investing cash flows cash flows cash flows cash flows Financing Financing cash flows cash flows Opening balance Closing balance Opening balance Closing balance ◼ Capital investment 10,688 ◼

  11. Slide 11: FY3/27 Full-Year Guidance

    FY3/27 Full-Year Guidance Copyright (C) SUNDRUG CO, LTD. ALL RIGHTS RESERVED. 11

  12. Slide 12: FY3/27 Business Plan

    FY3/27 Business Plan FY3/27 Full-year guidance Net sales ¥876.0 billion <YoY change> +4.0% Consolidated Operating income ¥48.8 billion <YoY change> +4.2% EBITDA ¥69.1 billion <YoY change> +5.2% Drugstore business Discount store business Net sales ¥554.0 billion <YoY change> +2.7% Net sales ¥386.0 bi

  13. Slide 13: Management Issues

    Management Issues Copyright (C) SUNDRUG CO, LTD. ALL RIGHTS RESERVED. 13

  14. Slide 14: [Business strategy] Store openings and group synergies

    [Business strategy] Store openings and group synergies ◼ Increase number of stores ◼ Maximize synergies Maintaining store opening standards while Full-scale product supply to begin in October 2026 targeting a net growth rate of at least 80% Number of stores Value of product supply to Kirindo Number

  15. Slide 15: [Business strategy] EC Business Strategy

    [Business strategy] EC Business Strategy ◼ Improve the convenience of our EC services and promote information channel strategies Improve the convenience of our EC services and leverage information channels EC results 1H FY3/27 Improve the convenience of our EC services Net sales 8,507 million (Break

  16. Slide 16: [Business strategy] Promote the dispensing pharmacy business

    [Business strategy] Promote the dispensing pharmacy business ◼ Initiatives to capture dispensing demand in regional communities Expansion driven by community-based strategies and digital transformation (DX) Dispensing results 1H FY3/27 Initiatives to enhance pharmacy functions ● Expansion of home ca

  17. Slide 17: [Reinforcement of business base] Improve productivity

    [Reinforcement of business base] Improve productivity ◼ Initiatives to further improve operational efficiency Electronic shelf labels Gross profit: +0.4% / Labor cost: -4.4% (1) Reducing labor costs (2) Improving gross (3) Reducing promotional Reduce time spent on in-store profits expenses tasks suc

  18. Slide 18: Contact

    Contact General Affairs Department, SUNDRUG Co., Ltd. [Address] 1-38-1 Wakamatsu-cho, Fuchu-shi, Tokyo 183-0005 [Phone] 042-369-6211 This document contains information on current business plans, earnings forecasts and projections that constitute forward-looking statements. These forward-looking stat

Sundrug — H1 FY3/27 Earnings Presentation on 6ix